Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Autosomal-dominant macular dystrophy linked to a chromosome 17 tandem duplication
Rabiat Adele, Rowaida Hussein, Erika Tavares, Kashif Ahmed, Matteo Di Scipio, Jason Charish, Minggao Liang, Simon Monis, Anupreet Tumber, Xiaoyan Chen, Tara A. Paton, Nicole M. Roslin, Christabel Eileen, Evgueni Ivakine, Nishanth E. Sunny, Michael D. Wilson, Eric Campos, Raju V.S. Rajala, Jason T. Maynes, Philippe P. Monnier, Andrew D. Paterson, Elise Héon, Ajoy Vincent
Rabiat Adele, Rowaida Hussein, Erika Tavares, Kashif Ahmed, Matteo Di Scipio, Jason Charish, Minggao Liang, Simon Monis, Anupreet Tumber, Xiaoyan Chen, Tara A. Paton, Nicole M. Roslin, Christabel Eileen, Evgueni Ivakine, Nishanth E. Sunny, Michael D. Wilson, Eric Campos, Raju V.S. Rajala, Jason T. Maynes, Philippe P. Monnier, Andrew D. Paterson, Elise Héon, Ajoy Vincent
View: Text | PDF
Research Article Genetics Ophthalmology

Autosomal-dominant macular dystrophy linked to a chromosome 17 tandem duplication

  • Text
  • PDF
Abstract

Hereditary macular dystrophies (HMDs) are a genetically diverse group of disorders that cause central vision loss due to photoreceptor and retinal pigment epithelium (RPE) damage. We investigated a family with a presumed novel autosomal-dominant HMD characterized by faint, hypopigmented RPE changes involving the central retina. Genome and RNA sequencing identified the disease-causing variant to be a 560 kb tandem duplication on chromosome 17 [NC_000017.10 (hg19): g.4012590_4573014dup], which led to the formation of a novel ZZEF1-ALOX15 fusion gene, which upregulates ALOX15. ALOX15 encodes a lipoxygenase involved in polyunsaturated fatty acid metabolism. Functional studies showed retinal disorganization and photoreceptor and RPE damage following electroporation of the chimera transcript in mouse retina. Photoreceptor damage also occurred following electroporation with a native ALOX15 transcript but not with a near-null ALOX15 transcript. Affected patients’ lymphoblasts demonstrated lower levels of ALOX15 substrates and an accumulation of neutral lipids. We implicated the fusion gene as the cause of this family’s HMD, due to mislocalization and overexpression of ALOX15, driven by the ZZEF1 promoter. To our knowledge, this is the first reported instance of a fusion gene leading to HMD or inherited retinal dystrophy, highlighting the need to prioritize duplication analysis in unsolved retinal dystrophies.

Authors

Rabiat Adele, Rowaida Hussein, Erika Tavares, Kashif Ahmed, Matteo Di Scipio, Jason Charish, Minggao Liang, Simon Monis, Anupreet Tumber, Xiaoyan Chen, Tara A. Paton, Nicole M. Roslin, Christabel Eileen, Evgueni Ivakine, Nishanth E. Sunny, Michael D. Wilson, Eric Campos, Raju V.S. Rajala, Jason T. Maynes, Philippe P. Monnier, Andrew D. Paterson, Elise Héon, Ajoy Vincent

×

Figure 7

Expression of chimeric and ALOX15 transcripts in mouse retinas.

Options: View larger image (or click on image) Download as PowerPoint
Expression of chimeric and ALOX15 transcripts in mouse retinas.
(A and B...
(A and B) P0 or P1 C57BL/6J mice were given subretinal injections of pT2K-IRES-eGFP (GFP control), pT2K-chimera-IRES-eGFP (chimera), pT2K-ALOX15-IRES-eGFP (ALOX15), or pT2K-CAGGS-IRES-eGFP-ALOX15-Thr560Met (T560M ALOX15) followed by electroporation of developing photoreceptors. Electroporated cells are labeled in green (GFP). Nuclei were labeled with DAPI (blue), rod outer segments were labeled with rhodopsin (red), and cones were labeled with cone arrestin (cyan). (A) At 28 days following electroporation, areas of the outer nuclear layer (ONL) that were electroporated with the chimera (top row) or ALOX15 (second row) constructs had a high incidence of rosette formation containing both cone and rod cells. Mice electroporated with both the T560M ALOX15 (third row) and control GFP (bottom row) constructs appeared normal. Three to 4 mice were analyzed in each construct group. (B) At 56 days following electroporation, areas of the ONL electroporated with the chimera (top row) or ALOX15 (second row) constructs appeared thinner than retinas electroporated with T560M ALOX15 (third row) and control GFP (bottom row). One to 3 mice were analyzed in each construct group. OS, outer segments; IS, inner segments; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. (C) P0 or P1 C57BL/6J mice were given subretinal injections of the chimera plasmid followed by electroporation of RPE. Nuclei were labeled with DAPI (blue), RPE cells were labeled with RPE65 (red), and actin cytoskeleton was labeled with phalloidin (yellow). Compared with GFP-electroporated RPE (left column), RPE electroporated with the chimera show abnormal morphology and exhibit RPE65 upregulation and phalloidin disorganization (right column). These features are consistent with severe RPE damage. Three to 5 mice were analyzed in each group. Images were taken at 20× original magnification. Scale bars: 50 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts